BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Biotech catalysts in 2024-06

205 industry Phase 2/3 trial readout(s) and 53 FDA decision event(s). Readouts include completed (ACTUAL) and still-estimated primary completion dates in this month, any status.

← 2024-05 | 2024-07 →

FDA decision events

DateEventStatusCompanyDrugSource
2024-06-04FDA AdComheldLykos TherapeuticsAdCom 2024-06-04: Psychopharmacologic Drugs Advisory Committee
2024-06-04FDA approvalapprovedALMAJECTTERIPARATIDEApproved 2024-06-04: TERIPARATIDE (NDA218771 ORIG1)
2024-06-05FDA AdComheldAdCom 2024-06-05: Vaccines and Related Biological Products Advisory Committee
2024-06-06FDA approvalapprovedGERON GERNRYTELOApproved 2024-06-06: RYTELO (NDA217779 ORIG1)
2024-06-07FDA approvalapprovedEISAI INCLENVIMAApproved 2024-06-07: LENVIMA (NDA206947 SUPPL31)
2024-06-07FDA approvalapprovedAUCTAMOTPOLY XRApproved 2024-06-07: MOTPOLY XR (NDA216185 SUPPL1)
2024-06-07FDA approvalapprovedMERCK SHARP DOHME MRKKEYTRUDAApproved 2024-06-07: KEYTRUDA (BLA125514 SUPPL154)
2024-06-07FDA approvalapprovedALMIRALLKLISYRIApproved 2024-06-07: KLISYRI (NDA213189 SUPPL5)
2024-06-10FDA AdComheldEli Lilly and Co. LLYAdCom 2024-06-10: Peripheral and Central Nervous System Drugs Advisory Committee
2024-06-10FDA approvalapprovedIPSENIQIRVOApproved 2024-06-10: IQIRVO (NDA218860 ORIG1)
2024-06-10FDA approvalapprovedSANOFI SYNTHELABO SNYKEVZARAApproved 2024-06-10: KEVZARA (BLA761037 SUPPL15)
2024-06-12Complete response lettercomplete responseXTM Consulting LLCCRL 2024-06-12: XTM Consulting LLC NDA 218698
2024-06-12FDA approvalapprovedLEO PHARMA ASADBRYApproved 2024-06-12: ADBRY (BLA761180 SUPPL6)
2024-06-12FDA approvalapprovedASTRAZENECA AB AZNXIGDUO XRApproved 2024-06-12: XIGDUO XR (NDA205649 SUPPL22)
2024-06-12FDA approvalapprovedELI LILLY AND CO LLYRETEVMOApproved 2024-06-12: RETEVMO (NDA218160 SUPPL1)
2024-06-12FDA approvalapprovedASTRAZENECA AB AZNFARXIGAApproved 2024-06-12: FARXIGA (NDA202293 SUPPL31)
2024-06-12FDA approvalapprovedELI LILLY AND CO LLYRETEVMOApproved 2024-06-12: RETEVMO (NDA213246 SUPPL9)
2024-06-13Complete response lettercomplete responseBayer HealthCare LLCCRL 2024-06-13: Bayer HealthCare LLC NDA 218506
2024-06-13FDA approvalapprovedBRISTOL BMYAUGTYROApproved 2024-06-13: AUGTYRO (NDA218213 SUPPL1)
2024-06-14Complete response lettercomplete responseRocket Pharmaceuticals, Inc. RCKTCRL 2024-06-14: Rocket Pharmaceuticals, Inc. BL 125806
2024-06-14Complete response lettercomplete responseNanocopoeia, LLC(nilotinib) orally disintegrating tabletsCRL 2024-06-14: Nanocopoeia, LLC NDA 217379 ((nilotinib) orally disintegrating tablets)
2024-06-14FDA approvalapprovedCOLLEGIUM PHARM INC COLLNUCYNTA ERApproved 2024-06-14: NUCYNTA ER (NDA200533 SUPPL29)
2024-06-14FDA approvalapprovedCOLLEGIUM PHARM INC COLLNUCYNTAApproved 2024-06-14: NUCYNTA (NDA022304 SUPPL28)
2024-06-14FDA approvalapprovedAMGEN AMGNBLINCYTOApproved 2024-06-14: BLINCYTO (BLA125557 SUPPL28)
2024-06-14FDA approvalapprovedASTRAZENECA UK LTD AZNIMFINZIApproved 2024-06-14: IMFINZI (BLA761069 SUPPL45)
2024-06-14FDA approvalapprovedCOLLEGIUM PHARM INC COLLNUCYNTAApproved 2024-06-14: NUCYNTA (NDA203794 SUPPL13)
2024-06-17FDA approvalapprovedMERCK SHARP DOHME MRKKEYTRUDAApproved 2024-06-17: KEYTRUDA (BLA125514 SUPPL155)
2024-06-17FDA approvalapprovedPYROS PHARMSVIGAFYDEApproved 2024-06-17: VIGAFYDE (NDA217684 ORIG1)
2024-06-18Complete response letterapproved sinceAbbVie Inc. ABBVVyalev (foscarbidopa and foslevodopa) injectionCRL 2024-06-18: AbbVie Inc. NDA 216962 (Vyalev (foscarbidopa and foslevodopa) injection)
2024-06-18FDA approvalapprovedABBVIE INC ABBVSKYRIZIApproved 2024-06-18: SKYRIZI (BLA761262 SUPPL7)
2024-06-18FDA approvalapprovedGENENTECHHERCEPTINApproved 2024-06-18: HERCEPTIN (BLA103792 SUPPL5354)
2024-06-18FDA approvalapprovedBOTANIX SBSOFDRAApproved 2024-06-18: SOFDRA (NDA217347 ORIG1)
2024-06-18FDA approvalapprovedABBVIE INC ABBVSKYRIZIApproved 2024-06-18: SKYRIZI (BLA761105 SUPPL29)
2024-06-18FDA approvalapprovedGENENTECH INCHERCEPTIN HYLECTAApproved 2024-06-18: HERCEPTIN HYLECTA (BLA761106 SUPPL10)
2024-06-20FDA approvalapprovedGENENTECH INCPIASKYApproved 2024-06-20: PIASKY (BLA761388 ORIG1)
2024-06-21FDA approvalapprovedARGENX BVVYVGART HYTRULOApproved 2024-06-21: VYVGART HYTRULO (BLA761304 SUPPL5)
2024-06-21FDA approvalapprovedBRISTOL BMYKRAZATIApproved 2024-06-21: KRAZATI (NDA216340 SUPPL5)
2024-06-21FDA approvalapprovedJANSSEN THERAPSIRTUROApproved 2024-06-21: SIRTURO (NDA204384 SUPPL19)
2024-06-21FDA approvalapprovedHARMONY HRMYWAKIXApproved 2024-06-21: WAKIX (NDA211150 SUPPL5)
2024-06-25FDA approvalapprovedSHORLATEPYLUTEApproved 2024-06-25: TEPYLUTE (NDA216984 ORIG1)
2024-06-26Complete response lettercomplete responseDaiichi Sankyo, Inc.CRL 2024-06-26: Daiichi Sankyo, Inc. BLA 761366
2024-06-26FDA approvalapprovedGENMAB US, INC. GMABEPKINLYApproved 2024-06-26: EPKINLY (BLA761324 SUPPL3)
2024-06-26FDA approvalapprovedMSDOHTUVAYREApproved 2024-06-26: OHTUVAYRE (NDA217389 ORIG1)
2024-06-26FDA approvalapprovedNOVARTIS PHARMS CORP NVSADAKVEOApproved 2024-06-26: ADAKVEO (BLA761128 SUPPL6)
2024-06-26FDA approvalapprovedMYLAN LABS LTDVANCOMYCIN HYDROCHLORIDEApproved 2024-06-26: VANCOMYCIN HYDROCHLORIDE (NDA209481 SUPPL24)
2024-06-27Complete response lettercomplete responseCELLTRION, Inc.CRL 2024-06-27: CELLTRION, Inc. BLA 761377
2024-06-28FDA approvalapprovedCOOPERSURGICALPARAGARD T 380AApproved 2024-06-28: PARAGARD T 380A (NDA018680 SUPPL74)
2024-06-28FDA approvalapprovedAVYXA HOLDINGSAXTLEApproved 2024-06-28: AXTLE (NDA210661 ORIG1)
2024-06-28FDA approvalapprovedSAMSUNG BIOEPIS CO LTDPYZCHIVAApproved 2024-06-28: PYZCHIVA (BLA761373 ORIG1)
2024-06-28FDA approvalapprovedFORMYCON AGAHZANTIVEApproved 2024-06-28: AHZANTIVE (BLA761378 ORIG1)
2024-06-28FDA approvalapprovedB BETTERCHEWTADZYApproved 2024-06-28: CHEWTADZY (NDA218527 ORIG1)
2024-06-28FDA approvalapprovedSAMSUNG BIOEPIS CO LTDPYZCHIVAApproved 2024-06-28: PYZCHIVA (BLA761425 ORIG1)
2024-06-28FDA approvalapprovedTANVEX BIOPHARMA USA INCNYPOZIApproved 2024-06-28: NYPOZI (BLA761126 ORIG1)

Trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2024-06 est.P2XEME Biopharma Inc.NCT02194751 Oncoquest-L Vaccine in Patients With Previously Untreated Stage III or IV, Asymptomatic, Non-bulky Follicular LymphomaFollicular Lymphomaunknown30
2024-06 est.P1/P2Navitas PharmaNCT02709031 Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and SodiumArterial Hypertension; Diabetes; Hypokalemia; Hyponatremiawithdrawn
2024-06 est.P3Infant Bacterial TherapeuticsNCT03978000 IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection StudyNecrotizing Enterocolitisactive not recruiting2158
2024-06 est.P3Torrent Pharmaceuticals LimitedNCT04507347 Efficacy and Safety of TRC041266 in Patients With Heart Failure, LVEF ≥40%, Diastolic Dysfunction and Type 2 Diabetes MellitusChronic Stable Heart Failurewithdrawn
2024-06 est.P2Anelixis Therapeutics, LLCNCT04711226 Safety, Tolerability and Efficacy of Immunomodulation With AT-1501 in Islet Cell TransplantationType 1 Diabetes Mellituswithdrawn
2024-06 est.P2Sorrento Therapeutics, Inc.NCT04809012 Study of STI-3031 in Patients With Selected Relapsed or Refractory Solid TumorsSolid Tumor; Refractory Tumor; Relapsed Solid Tumorwithdrawn
2024-06 est.P3GNT PharmaNCT05041010 Rescues On Reperfusion Damage In Cerebral Infarction by NelonemdazIschemic Strokeunknown496
2024-06 est.P1/P2Mabwell (Shanghai) Bioscience Co., Ltd.NCT05048160 A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant NeoplasmAdvanced Malignant Neoplasmunknown272
2024-06 est.P3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT05121350 A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With EpiruSoft Tissue Sarcomaunknown256
2024-06 est.P2Philogen S.p.A.NCT05329792 L19IL2/L19TNF in Skin Cancer PatientsBCC - Basal Cell Carcinoma; SCC - Squamous Cell Carcinoma; Merkel Cell Carcinoma; Keratoacanthoma ofunknown70
2024-06 est.P1/P2Shanghai Miracogen Inc.NCT05338957 A Study of MRG002 in the Treatment of Patients With HER2-expressed Advanced Malignant Solid Tumors.Advanced Malignant Solid Tumorsunknown30
2024-06 est.P2Clinuvel Europe Limited CUVLNCT05370235 A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and VXeroderma Pigmentosumunknown6
2024-06 est.P2Sorrento Therapeutics, Inc.NCT05372783 Study to Evaluate the Efficacy of IN STI-9199 in Treating Symptomatic COVID-19 in Outpatient Adults and AdolescentsCOVID-19withdrawn
2024-06 est.P1/P2Mabwell (Shanghai) Bioscience Co., Ltd.NCT05448599 A Clinical Study of 6MW3211 Monotherapy or Combination Therapy for AML or MDSAcute Myeloid Leukemia; Myelodysplastic Syndromeunknown120
2024-06 est.P1/P2Mabwell (Shanghai) Bioscience Co., Ltd.NCT05524194 6MW3511 in Patients With Advanced Solid TumorSolid Tumorsunknown272
2024-06 est.P1/P2ImmVira Pharma Co. LtdNCT05598268 A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.Advanced Solid Tumor; Lung Cancer; Liver Cancer; Lymphoma; Mesothelioma of Pleuraunknown74
2024-06 est.P3ITEL Telecomunicazioni SrlNCT05622162 Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7Prostate Cancer; 18F- Fluorocholine; PSMA PET; Radiotherapy; Prostatectomy; Tumor of Prostateunknown106
2024-06 est.P2Bio Genuine (Shanghai) Biotech Co., Ltd.NCT05738382 Efficacy and Safety of BG2109 During Controlled Ovarian Hyperstimulation in Female Subjects Undergoing ART ProceduresAssisted Reproductive Technology; Controlled Ovarian Hyperstimulationunknown240
2024-06 est.P3Blau Farmaceutica S.A.NCT05790096 Effectiveness and Safety Study of Filgrastine® in Patientes With Breast Cancer Treated With Myelotoxic ChemotherapyBreast Cancerunknown60
2024-06 est.P3Bio Genuine (Shanghai) Biotech Co., Ltd.NCT05894135 Efficacy and Safety of BG2109 in Chinese Subjects With EndometriosisEndometriosis; Moderate to Severe Endometriosis-associated Painunknown540
2024-06 est.P3Neutec Ar-Ge San ve Tic A.ŞNCT06040424 Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic ObstruCOPDunknown74
2024-06 est.P2Jiangsu HengRui Medicine Co., Ltd.NCT06144060 A Trial of Intravenous HRS-8427 in the Treatment of Adults With Complicate Urinary Tract Infection, Including Acute PyelonephritisPatients With Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP)unknown126
2024-06 est.P2Aimei Vacin BioPharm (Zhejiang) Co., Ltd.NCT06337071 A Study of the ACYW135 Meningococcal Polysaccharide Conjugate VaccineMeningococcal Meningitisunknown1200
2024-06 est.P3Shin Poong Pharmaceutical Co. Ltd.NCT06399042 Pivotal Study to Evaluate Efficacy and Safety of SP5M002 Inj. as Compared to Synovian Inj. in Patients With Mild to Moderate Knee OsteoarthritisOsteoarthritisunknown297
2024-06-01 est.P2Kenneth Krantz, MD, PhDNCT04843787 SLV213 Treatment in Ambulatory COVID-19 PatientsCovid19unknown81
2024-06-01 est.P2RemeGen Co., Ltd.NCT05297552 A Study of RC48-ADC Combined With JS001 For Perioperative Treatment of Muscle-Invasive Bladder CancerMuscle Invasive Bladder Carcinomaunknown40
2024-06-01 est.P1/P2Shanghai YingLi Pharmaceutical Co. Ltd.NCT05457517 A Phase 1b/2 Study of YL-13027 Combined With Sintilimab in Patients With Advanced Solid TumorsAdvanced Solid Tumorsunknown49
2024-06-02P1/P2BonusBio Group LtdNCT02842619 Filling Bone Defects/Voids With Autologous BonoFill-II for Maxillofacial Bone RegenerationBone Augmentation; Bone Graftscompleted27
2024-06-03P3Beijing Northland Biotech. Co., Ltd.NCT04275323 Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1)Arterial Occlusive Disease; Ischemia; Ulcers; Peripheral Vascular Diseasecompleted302
2024-06-03P2AmMax Bio, Inc.NCT05349643 A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCTPigmented Villonodular Synovitis; TGCT; Tenosynovial Giant Cell Tumorcompleted20
2024-06-03P3Daewoong Pharmaceutical Co. LTD.NCT06062030 Efficacy and Safety of DWJ1609 for Bowel Cleansing Before Colonoscopy;Colonoscopycompleted215
2024-06-04P2InflaRx GmbH IFRXNCT04812535 Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC.SCC - Squamous Cell Carcinoma of Skinterminated30
2024-06-04P2Hope Biosciences Research FoundationNCT05116540 Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple SclerosisMultiple Sclerosiscompleted24
2024-06-04P2Maruho Co., Ltd.NCT05214794 An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic SclerosisSystemic Sclerosiscompleted6
2024-06-04P3Merck Sharp & Dohme LLC MRKNCT05224141 Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-768Small Cell Lung Carcinomaactive not recruiting460
2024-06-04P2argenx ARGXNCT05225675 A Clinical Trial to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of 2 Dose Regimens of ARGX-117 in AMultifocal Motor Neuropathycompleted54
2024-06-04P2reMYNDNCT05478031 A Phase 2a Study to Investigate REM0046127 in Mild to Moderate Alzheimer's DiseaseAlzheimer Diseaseterminated14
2024-06-05P2Alector Inc. ALECNCT03987295 A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2)Frontotemporal Dementiacompleted33
2024-06-05P1/P2Vaccinex Inc. VCNXNCT04381468 SEMA4D Blockade Safety and Brain Metabolic Activity in Alzheimer's Disease (AD)Alzheimer Diseasecompleted50
2024-06-05P2Istari Oncology, Inc.NCT04479241 LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent GlioblastomaGlioblastoma; Recurrent Glioblastoma; Supratentorial Glioblastoma; Brain Tumorcompleted25
2024-06-05P3Novo Nordisk A/S NVONCT04560998 A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 DiabetesDiabetes Mellitus, Type 2; Peripheral Arterial Diseasecompleted792
2024-06-05P1/P2Precigen, Inc PGENNCT04724980 Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory PapillomatosisRecurrent Respiratory Papillomatosis; Papillomavirus Infections; Papillomaviridaeactive not recruiting38
2024-06-05P2Suzhou Suncadia Biopharmaceuticals Co., Ltd.NCT05055934 Study of the Effectiveness and Safety of SHR-1314 for Psoriatic ArthritisPsoriatic Arthritiscompleted112
2024-06-05P2Nerre Therapeutics Ltd.NCT05185089 Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary FibrosisCough; Idiopathic Pulmonary Fibrosiscompleted80
2024-06-05P2Celon Pharma SANCT05278156 Efficacy, Safety and Pharmacokinetics Study of CPL500036 (PDE10A Inhibitor) in Patients With SchizophreniaSchizophreniacompleted189
2024-06-05P2Inmune Bio, Inc. INMBNCT05522387 An Open-Label Extension of XPro1595 in Patients With Alzheimer's DiseaseAlzheimer Disease; Dementia; Brain Diseases; Central Nervous System Diseases; Nervous System Diseaseterminated11
2024-06-05P2Supernus Pharmaceuticals, Inc. SUPNNCT05619692 A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)Mild Cognitive Impairment; Mild Dementia; Alzheimer's Diseasecompleted174
2024-06-05P3Amgen AMGNNCT05651711 A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)Atopic Dermatitiscompleted726
2024-06-05P2Gan and Lee Pharmaceuticals, USANCT06256562 A Study of GZR18 Injection in Obese/Overweight PatientsObesity; Overweightcompleted340
2024-06-06P2/P3Serodus ASNCT04881123 SER150 vs Placebo in Diabetic Kidney DiseaseDiabetic Kidney Diseasecompleted20
2024-06-06P3Pfizer PFENCT04935879 A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive CrisesSickle Cell Disease; Vaso-occlusive Pain Episode in Sickle Cell Disease; Vaso-occlusive Crisiscompleted241
2024-06-06P2Kadmon, a Sanofi CompanyNCT05305989 Extended Treatment and Follow-up of Subjects Treated With Belumosudil in Study KD025-208 or Study KD025-213Chronic Graft-versus-host-diseasecompleted23
2024-06-07P2Nuvation Bio Inc. NUVBNCT04395677 A Study of AB-106 in Subjects With Advanced NSCLC Harboring ROS1 Fusion GeneNon Small Cell Lung Canceractive not recruiting173
2024-06-07P3BayerNCT04736199 Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate CancerProstatic Neoplasmscompleted669
2024-06-07P1/P2Stratatech, a Mallinckrodt CompanyNCT04765202 StrataGraft Overlay of Meshed Autograft in Full-thickness Thermal BurnsFull Thickness Thermal Burnterminated13
2024-06-07P1/P2Elucida OncologyNCT05001282 A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)Ovarian Cancer; Ovarian Neoplasms; Ovarian Carcinoma; Endometrial Cancer; Ovary Cancer; Ovary Neoplaterminated79
2024-06-07P2GlaxoSmithKlineNCT05630846 A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy ChMeasles; Mumps; Rubella; Chickenpox; Measlescompleted801
2024-06-07P3Novo Nordisk A/S NVONCT05723835 A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9SGA; Turner Syndrome; Noonan Syndrome; ISSactive not recruiting47
2024-06-07P3ModernaTX, Inc.NCT06060457 A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, Respiratory Syncytial Viruscompleted1900
2024-06-08P3H. Lundbeck A/SNCT05064371 Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in JapanMigrainecompleted160
2024-06-08P2GE HealthcareNCT05636852 Altropane Dose for Imaging Patients With Suspected Parkinson's DiseaseParkinson Disease; Movement Disordersterminated15
2024-06-09P2Jiangsu HengRui Medicine Co., Ltd.NCT05016323 A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Primary IgA Nephropathy.IgA Nephropathycompleted316
2024-06-09P3Shield TherapeuticsNCT05126901 Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficAnemia; Iron-deficiencycompleted65
2024-06-10P2Gyroscope Therapeutics LimitedNCT04566445 HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005Dry Age-related Macular Degenerationterminated255
2024-06-10P3Eli Lilly and Company LLYNCT06444165 Lebrikizumab Pen Ease of Use in Participants With Atopic DermatitisAtopic Dermatitiscompleted55
2024-06-11P3Merck Sharp & Dohme LLC MRKNCT03924869 Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small CelNon-Small Cell Lung Cancerterminated448
2024-06-11P3Kyntra Bio KYNBNCT03941093 Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINPancreatic Cancer Non-resectablecompleted284
2024-06-11P3AbbVie ABBVNCT04437433 A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic MigraineChronic Migraine; Episodic Migrainecompleted186
2024-06-11P1/P2SonALAsense, Inc.NCT05370508 A Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBMRecurrent GBMterminated8
2024-06-11P3Jiangsu HengRui Medicine Co., Ltd.NCT05702073 To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin.Type 2 Diabetes Mellituscompleted423
2024-06-11P1/P2Dawonmedax Co., Ltd.NCT05737212 Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade GliomasRecurrent High-grade Glioma; Recurrent Glioblastoma; Recurrent Anaplastic Astrocytoma; Recurrent Anaterminated7
2024-06-11P3Aldeyra Therapeutics, Inc. ALDXNCT06389214 A Clinical Trial to Assess the Efficacy and Safety of Subjects With Dry Eye DiseaseDry Eye Diseasecompleted132
2024-06-12P3Takeda TAKNCT02620046 A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's DiseaseColitis, Ulcerative; Crohn's Diseasecompleted746
2024-06-12P2Strata OncologyNCT05097599 StrataPATH™ (Precision Indications for Approved Therapies)Cancer; Advanced Solid Tumorterminated11
2024-06-12P3Biocon Biologics UK LtdNCT05345691 Comparison of Efficacy, Pharmacodynamics, Safety, and Immunogenicity Between Bmab 1000 and Prolia® in Postmenopausal Women With OsteoporosisPostmenopausal Women With Osteoporosiscompleted479
2024-06-12P2Celldex Therapeutics CLDXNCT05405660 A Study of CDX-0159 in Patients With Chronic Inducible UrticariaChronic Inducible Urticariacompleted196
2024-06-12P3Hangzhou Sciwind Biosciences Co., Ltd.NCT05680155 A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM PatientsT2DM; Type 2 Diabetes Mellituscompleted211
2024-06-12P2ViiV HealthcareNCT06214052 VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1HIV Infectionscompleted22
2024-06-13P3AEterna ZentarisNCT04786873 A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it isGrowth Hormone Deficiencycompleted101
2024-06-13P2Inversago Pharma Inc.NCT05891834 Study of INV-202 in Patients With Obesity and Metabolic SyndromeObesity; Metabolic Syndromecompleted243
2024-06-14P1/P2Eli Lilly and Company LLYNCT04145349 CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell TumorDesmoplastic Small Round Cell Tumorcompleted30
2024-06-14P2/P3Anavex Life Sciences Corp. AVXLNCT04314934 OLE of Phase 2b/3 Study ANAVEX2-73-AD-004Alzheimer Diseasecompleted300
2024-06-14P3Lupin Ltd.NCT04624750 Open Label Study in Adolescents and Children With Myotonic DisordersMyotonic Dystrophycompleted12
2024-06-14P2/P3ModernaTX, Inc.NCT04649151 A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19SARS-CoV-2completed4328
2024-06-14P2Atossa Therapeutics, Inc. ATOSNCT05068388 Effect of Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast DensityBreast Densitycompleted240
2024-06-14P2/P3Oui Therapeutics, Inc.NCT05144685 A Study to Evaluate the Safety and Effectiveness of a Digital TherapeuticSuicide, Attempted; Suicidal Ideationterminated356
2024-06-14P1/P2InventisBio Co., LtdNCT05492045 A Study to Evaluate D-1553 in Combination Therapy in Non-Small Cell Lung CancerNSCLCterminated22
2024-06-14P2Aventi Biotechnology Inc.NCT06788236 Study of Efficacy and Safety of AVTR101 in Sarcopenic ElderlySarcopeniaterminated100
2024-06-15 est.P2Shanghai Henlius BiotechNCT04984369 The Efficacy of HLX208 (BRAF V600E Inhibitor) With Cetuximab for Metastatic Colorectal Cancer (mCRC) With BRAF V600E Mutation After First-line TreatmentCRCunknown50
2024-06-15 est.P3Eiger BioPharmaceuticalsNCT05070364 Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDVHepatitis Delta Virusunknown150
2024-06-15P2Cardiol Therapeutics Inc. CRDLNCT05494788 Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)Recurrent Pericarditiscompleted27
2024-06-15P2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT05496569 TQB3616 Capsules in the Treatment of Dedifferentiated LiposarcomaDedifferentiated Liposarcomaterminated26
2024-06-15 est.P2/P3Shanghai Henlius BiotechNCT05633433 Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19SARS-CoV-2 Infectionunknown1550
2024-06-15 est.P2Tarsus Pharmaceuticals, Inc. TARSNCT06054217 Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With DemodexMeibomian Gland Dysfunction; Demodex Infestation of Eyelid; Blepharitis; Demodectic Blepharitisunknown36
2024-06-16P2Takeda TAKNCT05020015 A Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)active not recruiting27
2024-06-17P3Pfizer PFENCT04370054 Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A AdultsHemophilia Aactive not recruiting77
2024-06-17P2Paratek Pharmaceuticals IncNCT04922554 Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc)Mycobacterium Infections, Nontuberculous; Mycobacterium Abscessus Infection; Nontuberculous Mycobactcompleted66
2024-06-17P2/P3PTC Therapeutics PTCNCT05269355 A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)Leiomyosarcomaterminated359
2024-06-17P3LEO PharmaNCT05295732 The ASCEND Study: Evaluating TMB-001 in the Treatment of RXLI or ARCI IchthyosisIchthyosiscompleted153
2024-06-17P2Bristol-Myers Squibb BMYNCT05613088 A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary PeritoneaNeoplasms, Ovarianterminated106
2024-06-17P3Otsuka Beijing Research InstituteNCT05667623 To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With ADAtopic Dermatitis (AD)completed270
2024-06-17P2Photozig, Inc.NCT05979922 Mindfulness-based Cognitive Coping for ADRD CaregiversCaregiver Stresscompleted174
2024-06-17P2Enanta Pharmaceuticals, Inc ENTANCT06170242 A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection in a Virus Challenge ModelRSV Infectioncompleted142
2024-06-17P2/P3Hipra Scientific, S.L.UNCT06181292 Safety and Immunogenicity of a Booster Vaccination With an Adapted VaccineSARS-CoV2 Infectioncompleted913
2024-06-17P3Shanghai Auzone Biological Technology Co., Ltd.NCT06648304 Evaluate the Efficacy and Safety of TTYP01 Tablets in the Treatment of Acute Ischemic StrokeAcute Ischemic Strokecompleted614
2024-06-17P3Shenzhen Salubris Pharmaceuticals Co., Ltd.NCT06720025 Study of SAL-0951 Compared to Recombinant Human Erythropoietin in Anemic Patients Receiving Maintenance HemodialysisAnemiacompleted100
2024-06-18P1/P2Hutchmed HCMNCT04577963 A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid TumorsTriple Negative Breast Cancer; Endometrial Cancer; Solid Tumor, Unspecified, Adult; Colorectal Canceterminated52
2024-06-18P3Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT04923906 Aumolertinib with or Without Chemotherapy As 1st Line Treatment in Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Sensitizing EGFR MutationsNon-small Cell Lung Canceractive not recruiting624
2024-06-18P2Yamo Pharmaceuticals LLCNCT05067582 A 12-Week Crossover Study to Assess the Efficacy, Safety and Tolerability of L1-79 in Subjects Aged 12-21 Years With Autism Spectrum DisorderAutism Spectrum Disorder; Autismcompleted58
2024-06-19P2Pfizer PFENCT04607837 Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative ColitisUlcerative Colitiscompleted234
2024-06-19P3Hoffmann-La RocheNCT04740918 A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-PositivMetastatic Breast Cancerterminated96
2024-06-19P2AEON Biopharma, Inc. AEONNCT04845178 Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in AdultsMigrainecompleted797
2024-06-19P2Advantage Silver Dental Arrest, LLCNCT04947527 Efficacy and Safety Evaluation of Anti-Caries VarnishDental Caries in Childrencompleted274
2024-06-19P3OPKO Health, Inc. OPKNCT05543928 Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary HyperparathyroidismChronic Kidney Disease stage3; Chronic Kidney Disease stage4; Vitamin d Deficiency; Secondary Hyperpterminated2
2024-06-19P3Janssen Research & Development, LLCNCT06095102 A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the SolesPlaque Psoriasisactive not recruiting311
2024-06-20P3BiocadNCT05732805 A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With UnresectaMelanoma; Melanoma (Skin); Melanoma Stage III; Melanoma Stage IV; Melanoma Unresectable; Melanoma Meactive not recruiting270
2024-06-20P3Novartis Pharmaceuticals NVSNCT05763875 Efficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy.Hypercholesterolemiacompleted350
2024-06-20P2Hoffmann-La RocheNCT05775289 A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Untreated Non-Small CeNon-small Cell Lung Cancercompleted182
2024-06-20P3Hangzhou Sciwind Biosciences Co., Ltd.NCT05813795 A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or ObesityWeight Managementcompleted664
2024-06-20P2KEB Nutraceuticals USA, Inc.NCT06719115 A Clinical Trial to Investigate the Safety and Efficacy of D-Mannose on Symptoms of Urinary Tract Infection in WomenUrinary Tract Infection(UTI)completed30
2024-06-20P3Kyungdong Pharmaceutical Co., Ltd.NCT07116863 A Multicenter, Randomized, Double-Blind Phase 3 Trial of KDF1901 in Patients With Essential HypertensionEssential Hypertensioncompleted286
2024-06-21P2/P3Incyte Corporation INCYNCT02763319 A Trial to Evaluate the Efficacy and Safety of Tafasitamab With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or RefractoryDiffuse Large B-cell Lymphomacompleted453
2024-06-21P1/P2invoX Pharma LimitedNCT03440437 A Phase 1/2 Study of FS118 in Patients With Advanced MalignanciesAdvanced Cancer; Metastatic Cancer; Squamous Cell Carcinoma of Head and Neckterminated80
2024-06-21P2Merck Sharp & Dohme LLC MRKNCT04624243 Efficacy and Safety of Elpipodect (MK-8189) in Participants With an Acute Episode of Schizophrenia (MK-8189-008)Schizophreniacompleted499
2024-06-21P1/P2Astellas Pharma Global Development, Inc.NCT04837196 Study of ASP7517 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors Expressing WT1 AntigenAdvanced Malignancies; Advanced Cancercompleted24
2024-06-21P2Innovent Biologics (Suzhou) Co. Ltd.NCT05377580 A Study to Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative ColitisUlcerative Colitis (UC)completed150
2024-06-21P2RAPT Therapeutics, Inc., a member of the GSK plc group of companiesNCT05935332 Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high AsthmaAsthmaterminated38
2024-06-21P1/P2AkesoNCT06035354 A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of AK120 in Subjects With Atopic DermatitisAtopic Dermatitiscompleted427
2024-06-23P3AstraZeneca AZNNCT03706690 A Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer PatientsCarcinoma, Non-Small-Cell Lungactive not recruiting407
2024-06-24P2Novartis Pharmaceuticals NVSNCT04814368 A Safety and Efficacy Study of Anti-inflammatory (Canakinumab) and Cartilage Stimulating (LNA043) Drugs Injected Into the Knee Joint of Participants With Knee OKnee Osteoarthritisterminated23
2024-06-24P3Eli Lilly and Company LLYNCT04975308 A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast CancerBreast Neoplasms; Neoplasm Metastasisactive not recruiting874
2024-06-24P2Shanghai HEP Pharmaceutical Co., Ltd.NCT05244057 A Study of Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B PatientsChronic Hepatitis Bcompleted8
2024-06-24P3Chiesi Farmaceutici S.p.A.NCT05292586 A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or Asthmacompleted1377
2024-06-24 est.P2Bristol-Myers Squibb BMYNCT05496192 A Study of Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder CancerMelanoma; Urothelial Carcinomawithdrawn
2024-06-24P2Smilebiotek Zhuhai LimitedNCT05562219 QA108 Phase II Study in Subjects With Intermediate Age-Related Macular DegenerationIntermediate Age-Related Macular Degenerationcompleted120
2024-06-24P3ModernaTX, Inc.NCT05827978 Study of mRNA-1010 Seasonal Influenza Vaccine in AdultsSeasonal Influenzacompleted8411
2024-06-24P2ViiV HealthcareNCT06039579 Proof of Concept Treatment Study of Orally Administered VH4004280 or VH4011499 in HIV-1 Infected AdultsHIV Infectionscompleted44
2024-06-25P1/P2Gyroscope Therapeutics LimitedNCT03846193 FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMDDry Age-related Macular Degeneration; Macular Degeneration; Retinal Disease; Eye Diseases; Retinal Dterminated56
2024-06-25P3Pfizer PFENCT04006457 Long-Term PF-06651600 for the Treatment of Alopecia AreataAlopecia Areatacompleted1057
2024-06-25P1/P2Ascentage Pharma Group Inc. AAPGNCT04643405 APG-1387 Plus Chemotherapy in Advanced Pancreatic AdenocarcinomaAdvanced Pancreatic Cancerterminated21
2024-06-25P2Resilient PharmaceuticalsNCT04784143 Study Comparing Two Versus Three Active MDMA-assisted Sessions in U.S. Military Veterans With Chronic PTSDPTSDterminated26
2024-06-25P1/P2Laekna LimitedNCT05383482 Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1Solid Tumor; NSCLC; Cervical Cancer; Endometrial Cancer; Esophageal Cancer; Gastric and Gastroesophacompleted22
2024-06-25P3Keymed Biosciences Co.LtdNCT05436275 A Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyposis (CROWNS-2)Chronic Rhinosinusitis With Nasal Polyposiscompleted180
2024-06-25P2SOM Innovation Biotech SANCT05475483 Efficacy and Safety on SOM3355 in Huntington's Disease ChoreaHuntington Choreacompleted139
2024-06-25P2Redx Pharma LtdNCT05570058 Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary FibrosisIPF; Fibrosisactive not recruiting48
2024-06-25P2GlaxoSmithKlineNCT05921903 A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Respiratory Syncytial Virus Infectionscompleted386
2024-06-26P3Pharmacyclics LLC.NCT03112174 Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)Mantle-Cell Lymphomacompleted366
2024-06-26P3Eli Lilly and Company LLYNCT04752332 A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast CancerBreast Neoplasmsterminated111
2024-06-26P3Apellis Pharmaceuticals, Inc.NCT05067127 Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative GlomerulonephritisC3G; IC-MPGN; C3 Glomerulopathy; C3 Glomerulonephritis; Complement 3 Glomerulopathy; Complement 3 Glcompleted124
2024-06-26P2Novartis Pharmaceuticals NVSNCT05124925 Biopsy Based Study to Understand Mechanism of Action of Ianalumab in Salivary Glands and Explore Relationships With Clinical Assessments.Sjogren Syndromecompleted21
2024-06-26P2Janssen Research & Development, LLCNCT05201794 A Study of JNJ-64281802 for the Prevention of Dengue InfectionDengueterminated1595
2024-06-26P2Gilead Sciences GILDNCT05330429 Study of Magrolimab Given Together With FOLFIRI/Bevacizumab (BEV) in Participants With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRCMetastatic Colorectal Cancerterminated77
2024-06-26P2Tarsus Pharmaceuticals, Inc. TARSNCT05387083 A Human Tick Kill Study to Investigate the Safety, Tolerability, and Whole Blood Concentration of TP-05Healthy Volunteercompleted30
2024-06-26P3Pfizer PFENCT05561140 Resolution of Sickle Cell Leg Ulcers With VoxelotorSickle Cell Disease; Leg Ulcersterminated88
2024-06-26P2Berlin Cures GmbHNCT05911009 To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVIDLong Covidcompleted119
2024-06-26P3POLYSAN Scientific & Technological Pharmaceutical CompanyNCT05935787 Cytoflavin in the Complex Rehabilitation of Stroke PatientsStrokecompleted240
2024-06-26P2Zydus Lifesciences LimitedNCT05981040 Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZYIL1 in Patients With Amyotrophic Lateral SclerosisAmyotrophic Lateral Sclerosiscompleted24
2024-06-27P3Otsuka Pharmaceutical Development & Commercialization, Inc.NCT04408755 Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeAgitation in Patients With Dementia of the Alzheimer's Typeterminated184
2024-06-27P2Neuraptive Therapeutics Inc.NCT04572906 Safety and Efficacy of NTX-001 Compared to SOC in Acute Single Peripheral Nerve InjuriesPeripheral Nerve Injuriescompleted51
2024-06-27P3OctapharmaNCT05523297 Active-control Randomized Trial Comparing 4-factor Prothrombin Complex Concentrate With Frozen Plasma in Cardiac SurgeryBleeding Cardiac Surgery Patientscompleted420
2024-06-27P2Ventyx Biosciences, IncNCT05688852 VTX958 for the Treatment of Moderately to Severely Active Crohn's DiseaseCrohn Diseaseterminated107
2024-06-27P1/P2Urica Therapeutics Inc.NCT06056570 Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With HyperuricemiaGout; Hyperuricemiacompleted20
2024-06-28P3AbbVie ABBVNCT03271489 Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine FiHeavy Menstrual Bleeding; Uterine Fibroidscompleted478
2024-06-28P2Tesaro, Inc.NCT03574779 A Study to Evaluate the Efficacy and Safety of Novel Treatment Combinations in Participants With Ovarian CancerOvarian Neoplasmscompleted77
2024-06-28P3Merck Sharp & Dohme LLC MRKNCT03833167 Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNCarcinoma, Squamous Cellterminated450
2024-06-28P3Hinova Pharmaceuticals USA, Inc.NCT03850795 HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)Prostate Cancer Metastatic; Castration-resistant Prostate Cancerterminated104
2024-06-28P3AbbVie ABBVNCT04201093 Fixed-Dose Trial in Early Parkinson's Disease (PD)Parkinson Diseasecompleted529
2024-06-28P3Otsuka Pharmaceutical Development & Commercialization, Inc.NCT04464564 Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeAgitation in Patients With Dementia of the Alzheimer's Typeterminated241
2024-06-28P1/P2AkesoNCT04900363 A Trial of AK112 (PD-1/VEGF Bispecific Antibody) in Patients With NSCLCNon-small Cell Lung Cancercompleted108
2024-06-28P3GlaxoSmithKlineNCT04915755 Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene MNeoplasms, Breastactive not recruiting40
2024-06-28 est.P1/P2Genor Biopharma Co., Ltd.NCT04923048 A Safety, Tolerability, Pharmacokinetics and Efficacy Study of GB261 in B-Cell NHL and CLL.B Cell NHL; CLLunknown460
2024-06-28P2Neurocrine Biosciences NBIXNCT05182476 Study to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With SchizophreniaSchizophreniaterminated216
2024-06-28P3Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT05255237 Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia AreataAlopecia Areatacompleted315
2024-06-28P2Gan and Lee Pharmaceuticals, USANCT06199505 A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects with T2DMType 2 Diabetescompleted153
2024-06-28P2Shanghai Ark Biopharmaceutical Co., Ltd.NCT06942299 A Study of AK0529 in Adults Patients Hospitalized With RSV InfectionRespiratory Syncytial Virus Infectionscompleted25
2024-06-28P2Tesaro, Inc.NCT06964165 A Study Comparing Niraparib Versus Platinum-Taxane Doublet Chemotherapy as Neoadjuvant Treatment in Participants With Homologous Recombination-Deficient Stage IOvarian Neoplasmsterminated36
2024-06-29P1/P2Qilu Pharmaceutical Co., Ltd.NCT05052567 CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal AdenocarcinomaPancreatic Cancercompleted50
2024-06-29P2Beijing Suncadia Pharmaceuticals Co., LtdNCT06009393 Evaluate the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial HypercholesterolemiaHomozygous Familial Hypercholesterolemiacompleted26
2024-06-29P3AstraZeneca AZNNCT06245551 A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction inAsthma, Exercise-Inducedcompleted64
2024-06-30P2Teclison Ltd.NCT03145558 TATE Versus TACE in Intermediate Stage HCCCarcinoma, Hepatocellularterminated6
2024-06-30 est.P1/P2Longeveron Inc. LGVNNCT03525418 Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)HLHSunknown10
2024-06-30 est.P2United BioPharma UTHRNCT03595995 A Phase 2 Trial to Evaluate the Safety and Efficacy of UB-621Genital Herpesunknown80
2024-06-30 est.P3S.L.A. Pharma AGNCT03806426 Effect of EPA-FFA on Polypectomy in Familial Adenomatous PolyposisFamilial Adenomatous Polyposisunknown204
2024-06-30P3Cordgenics, LLCNCT03949283 Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian CancerRecurrent Ovarian Carcinoma; Platinum-resistant Ovarian Canceractive not recruiting150
2024-06-30P3TJ Biopharma Co., Ltd.NCT03952091 TJ202, Lenalidomide and Dexamethasone vs. Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple MyelomaMultiple Myeloma in Relapse; Refractory Multiple Myelomacompleted289
2024-06-30 est.P2ISA PharmaceuticalsNCT04398524 A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPCSquamous Cell Carcinoma of the Oropharynxunknown65
2024-06-30 est.P2UBP Greater China (Shanghai) Co., LtdNCT04404049 The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 PatientsHIV-1-infectionunknown39
2024-06-30 est.P1/P2Tayu Huaxia Biotech Medical Group Co., Ltd.NCT04458389 A Phase 1/2 Study of TY101 for Locally Advanced /Metastatic Solid Tumors and Relapsed or Refractory LymphomasLocally Advanced /Metastatic Solid Tumors; Relapsed or Refractory Lymphomasunknown268
2024-06-30 est.P1/P2Innovent Biologics (Suzhou) Co. Ltd.NCT04485052 Efficacy and Safety Evaluation of IBI188 in Combination With Demethylating Agents in Treatment of Patients With Acute Myeloid LeukemiaAcute Myeloid Leukemiasuspended222
2024-06-30P3Swedish Orphan BiovitrumNCT05001737 Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLEMacrophage Activation Syndrome; Secondary Hemophagocytic Lymphohistiocytosis; Still Disease; Systemicompleted33
2024-06-30 est.P2Shanghai Henlius BiotechNCT05092815 The Efficacy and Safety of HLX208 in Adult Langerhans Cell Histiocytosis (LCH) and Erdheim-Chester Disease (ECD) With BRAF V600E MutationLangerhans Cell Histiocytosis; Erdheim-Chester Disease; LCH; ECDunknown25
2024-06-30 est.P1/P2Shanghai Henlius BiotechNCT05102292 The Efficacy and Safety of HLX208 in Advanced Anaplastic Thyroid Cancer (ATC) With BRAF V600 MutationAnaplastic Thyroid Cancer; ATCunknown25
2024-06-30P1/P2Cardix Therapeutics LLCNCT05117346 An Exploratory Safety and Efficacy Clinical Study of CARDIX-101 for the Treatment of Chronic BradycardiaBradycardiacompleted20
2024-06-30 est.P2TJ Biopharma Co., Ltd.NCT05145907 Study to Evaluate Safety and Efficacy of TJ107 Combine With PD-1 in Patients With Solid TumorsTriple-negative Breast Cancer; Head and Neck Squamous Cell Carcinomaunknown133
2024-06-30P3IBSA Institut Biochimique SANCT05171673 Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants With Minor Soft Tissue InjurySoft Tissue Injuriescompleted151
2024-06-30 est.P2Shanghai Henlius BiotechNCT05221658 A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy or Monotherapy in Patients With Advanced ESCCESCC or Esophageal Adenosquamous Carcinomaunknown60
2024-06-30 est.P2Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.NCT05284812 A Phase Ⅱ Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)Tuberculosissuspended200
2024-06-30 est.P1/P2Genor Biopharma Co., Ltd.NCT05332574 A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid TumorNSCLC; Other Solid Tumorsunknown120
2024-06-30 est.P2MitoImmune TherapeuticsNCT05493800 Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCTOral Mucositis; Lymphoma; Multiple Myeloma; Hematologic Cancerunknown60
2024-06-30 est.P3Jiangsu HengRui Medicine Co., Ltd.NCT05685420 Extension Study of Herombopag for Pediatric Patients With Chronic Immune ThrombocytopeniaImmune Thrombocytopeniaunknown117
2024-06-30P2/P3Hoffmann-La RocheNCT05694013 Clinical Impact and Utility of Digital Health Solutions in Participants Receiving Systemic Treatment in Clinical PracticeCancerterminated49
2024-06-30 est.P2Connect Biopharm LLC CNTBNCT05905133 A Study to Evaluate the Safety and Efficacy of CBP-201 in Chinese Adult Subjects With Moderate to Severe ADAtopic Dermatitisunknown360
2024-06-30 est.P1/P2Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT05964790 Safety, Tolerability, Pharmacokinetics and Efficacy Study of HS-10380 in Patients With SchizophreniaSchizophreniaunknown112
2024-06-30 est.P2NeuroRx, Inc.NCT06128213 NRX-101 for Complicated Urinary Tract Infection (UTI) Including PyelonephritisUrinary Tract Infections; Pyelonephritisunknown13
2024-06-30 est.P3ORA, Inc.NCT06178679 Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED)Dry Eye Diseaseunknown175

← 2024-05 | 2024-07 →

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.